NCT01317186Unknown不适用
The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney Disease
Ankara Education and Research Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年3月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
In chronic kidney disease calcium (Ca) and phosphate (P) metabolism disorders are very common and also they are one of the leading causes of morbidity in these population. FGF23 is a novel factor that contributes Ca-P disorders. It has been hypothesized that FGF 23 increase is mediated by asymmetric dimethylarginine (ADMA). The aim of the study is to evaluate this hypothesis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •between ages of 18 - 65 years old
- •chronic kidney disease of stage 2-4
排除标准
- •presence of diabetes mellitus or ischemic hearth disease
- •taking vitamin d therapy
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Effect of Phosphate Binders on FGF-23 With Concurrent CalcitriolChronic Kidney Disease Stage 3NCT01748396Seoul National University Hospital30
Unknown
不适用
Factors Related to the Progression of Chronic Kidney DiseaseChronic Kidney DiseaseNCT01317173Ankara Education and Research Hospital90
已完成
不适用
Plasma Concentrations of Calcium, Phosphate, FGF23, Klotho, 25 (OH) D3 and 1,25 (OH) 2D3 from Patients Who Wants to Have ChildrenInfertility, FemaleNCT03173235University Hospital Tuebingen80
已完成
不适用
Mediators of Kidney-Bone Communication in ChildhoodFasting Blood MeasuresBody ScansNCT02040740University of Alabama at Birmingham26
已完成
1 期
Role Of Phosphorus And FGF 23 In Patients With Dent DiseaseDent DiseaseNCT02016235Mayo Clinic30